Gene expression network analysis provides potential targets against SARS-CoV-2

Abstract Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). We aimed to identify and characterize genes that are co-expressed with ACE2 and TMPRSS2, and to further explore...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana I. Hernández Cordero, Xuan Li, Chen Xi Yang, Stephen Milne, Yohan Bossé, Philippe Joubert, Wim Timens, Maarten van den Berge, David Nickle, Ke Hao, Don D. Sin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/04a4ce5f742b4fb4a05cf20cbace41a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:04a4ce5f742b4fb4a05cf20cbace41a1
record_format dspace
spelling oai:doaj.org-article:04a4ce5f742b4fb4a05cf20cbace41a12021-12-02T12:03:15ZGene expression network analysis provides potential targets against SARS-CoV-210.1038/s41598-020-78818-w2045-2322https://doaj.org/article/04a4ce5f742b4fb4a05cf20cbace41a12020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78818-whttps://doaj.org/toc/2045-2322Abstract Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). We aimed to identify and characterize genes that are co-expressed with ACE2 and TMPRSS2, and to further explore their biological functions and potential as druggable targets. Using the gene expression profiles of 1,038 lung tissue samples, we performed a weighted gene correlation network analysis (WGCNA) to identify modules of co-expressed genes. We explored the biology of co-expressed genes using bioinformatics databases, and identified known drug-gene interactions. ACE2 was in a module of 681 co-expressed genes; 10 genes with moderate-high correlation with ACE2 (r > 0.3, FDR < 0.05) had known interactions with existing drug compounds. TMPRSS2 was in a module of 1,086 co-expressed genes; 31 of these genes were enriched in the gene ontology biologic process ‘receptor-mediated endocytosis’, and 52 TMPRSS2-correlated genes had known interactions with drug compounds. Dozens of genes are co-expressed with ACE2 and TMPRSS2, many of which have plausible links to COVID-19 pathophysiology. Many of the co-expressed genes are potentially targetable with existing drugs, which may accelerate the development of COVID-19 therapeutics.Ana I. Hernández CorderoXuan LiChen Xi YangStephen MilneYohan BosséPhilippe JoubertWim TimensMaarten van den BergeDavid NickleKe HaoDon D. SinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ana I. Hernández Cordero
Xuan Li
Chen Xi Yang
Stephen Milne
Yohan Bossé
Philippe Joubert
Wim Timens
Maarten van den Berge
David Nickle
Ke Hao
Don D. Sin
Gene expression network analysis provides potential targets against SARS-CoV-2
description Abstract Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). We aimed to identify and characterize genes that are co-expressed with ACE2 and TMPRSS2, and to further explore their biological functions and potential as druggable targets. Using the gene expression profiles of 1,038 lung tissue samples, we performed a weighted gene correlation network analysis (WGCNA) to identify modules of co-expressed genes. We explored the biology of co-expressed genes using bioinformatics databases, and identified known drug-gene interactions. ACE2 was in a module of 681 co-expressed genes; 10 genes with moderate-high correlation with ACE2 (r > 0.3, FDR < 0.05) had known interactions with existing drug compounds. TMPRSS2 was in a module of 1,086 co-expressed genes; 31 of these genes were enriched in the gene ontology biologic process ‘receptor-mediated endocytosis’, and 52 TMPRSS2-correlated genes had known interactions with drug compounds. Dozens of genes are co-expressed with ACE2 and TMPRSS2, many of which have plausible links to COVID-19 pathophysiology. Many of the co-expressed genes are potentially targetable with existing drugs, which may accelerate the development of COVID-19 therapeutics.
format article
author Ana I. Hernández Cordero
Xuan Li
Chen Xi Yang
Stephen Milne
Yohan Bossé
Philippe Joubert
Wim Timens
Maarten van den Berge
David Nickle
Ke Hao
Don D. Sin
author_facet Ana I. Hernández Cordero
Xuan Li
Chen Xi Yang
Stephen Milne
Yohan Bossé
Philippe Joubert
Wim Timens
Maarten van den Berge
David Nickle
Ke Hao
Don D. Sin
author_sort Ana I. Hernández Cordero
title Gene expression network analysis provides potential targets against SARS-CoV-2
title_short Gene expression network analysis provides potential targets against SARS-CoV-2
title_full Gene expression network analysis provides potential targets against SARS-CoV-2
title_fullStr Gene expression network analysis provides potential targets against SARS-CoV-2
title_full_unstemmed Gene expression network analysis provides potential targets against SARS-CoV-2
title_sort gene expression network analysis provides potential targets against sars-cov-2
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/04a4ce5f742b4fb4a05cf20cbace41a1
work_keys_str_mv AT anaihernandezcordero geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT xuanli geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT chenxiyang geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT stephenmilne geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT yohanbosse geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT philippejoubert geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT wimtimens geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT maartenvandenberge geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT davidnickle geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT kehao geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
AT dondsin geneexpressionnetworkanalysisprovidespotentialtargetsagainstsarscov2
_version_ 1718394729718087680